Nieman Richard 4
4 · Lyra Therapeutics, Inc. · Filed Jul 12, 2022
Insider Transaction Report
Form 4
Nieman Richard
Chief Medical Officer
Transactions
- Award
Stock Option
2022-07-11+230,000→ 230,000 totalExercise: $6.08Exp: 2032-07-10→ Common Stock (230,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable as to 25% of the underlying shares on July 11, 2023 and in 36 substantially equal monthly installments thereafter.